Response to Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment
Crossref DOI link: https://doi.org/10.1007/s40292-017-0230-3
Published Online: 2017-09-04
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Scullin, Evan
License valid from 2017-09-04
